Source: International Congress 2014 – Animal models in respiratory drug development
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Mayse, P. Johnson, J. Hummel (Minneapolis, Chapel Hill, United States Of America). Importance of surface cooling during targeted lung denervation for COPD. Eur Respir J 2014; 44: Suppl. 58, 1793

Member's Comments

No comment yet.

Related content which might interest you: Targeted lung denervation in the healthy sheep model - A potential treatment for COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Anti-inflammatory effects of targeted lung denervation in patients with COPD Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Efficacy of targeted lung denervation in patients with moderate to severe COPD Source: International Congress 2014 – Bronchoscopic treatment of emphysema: where are we? Year: 2014 Safety and feasibility of targeted lung denervation in patients with moderate to severe COPD Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other Year: 2014 Bilateral targeted lung denervation in patients with COPD in a single procedure Source: International Congress 2014 – Bronchoscopic treatment of emphysema: where are we? Year: 2014 Effectively targeting small airways using controlled inhalation for peripheral corticosteroid deposition Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Cost-effectiveness of bronchial thermoplasty (BT) treatment relative to no BT treatment option for patients with severe asthma Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Endobronchial ultrasound in study of airway wall remodeling in COPD patients Source: International Congress 2014 – COPD exacerbations Year: 2014 Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Lung volume reduction coil treatment restores lung compliance in patients with homogeneous emphysema Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Forced oscillations technique canhighlight the effects of bronchial airways clearance in COPD Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Role of chest expansion in pulmonary rehabilitation Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 Effect of aclidinium/formoterol fixed-dose combinations on respiratory symptoms in COPD patients Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Are ultrafine particle inhalers, better for patients with small airway involvement? Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Treatment of combined pulmonary fibrosis and emphysema Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Use of SLP to identify disordered thoraco-abdominal breathing patterns in COPD Source: International Congress 2014 – Respiratory function: quality and new technologies Year: 2014 Body-plethysmographic measurements of bronchodilator response in stable COPD Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014